Advances in CAR-NK cell therapy for hematological malignancies
R Yang, Y Yang, R Liu, Y Wang, R Yang… - Frontiers in …, 2024 - frontiersin.org
Chimeric antigen receptor T (CAR-T) cell therapy has revolutionized the treatment of
hematological malignancies, demonstrably improving patient outcomes and prognosis …
hematological malignancies, demonstrably improving patient outcomes and prognosis …
An extended flow cytometry evaluation of ex vivo expanded NK cells using K562. Clone1, a feeder cell line manufactured in Brazil
CM Watanabe, CI Suzuki, AM dos Santos… - … and Cellular Therapy, 2024 - Elsevier
ABSTRACT Background Natural Killer (NK) cells play a crucial role in the immune system's
response against cancer. However, the challenge of obtaining the required quantity of NK …
response against cancer. However, the challenge of obtaining the required quantity of NK …
Combined Dendritic Cell And Anti-TIGIT Immunotherapy Potentiate Trail+ Memory NK Cells Against HIV-1 Infected Cells
IS Cerrillo, O Popova, MA Lera, I Tsukalov… - bioRxiv, 2024 - biorxiv.org
Natural Killer (NK) cells are promising tools for the development of immunotherapies
targeting persistently infected CD4+ T cells to potentially achieve remission in people with …
targeting persistently infected CD4+ T cells to potentially achieve remission in people with …